chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case involves 11-years-old male patient who experienced itching at the injection site (vaccination site pruritus), vaccination site inflammation, redness at the injection site (vaccination site erythema) and mild swelling at the injection site (vaccination site swelling) when received MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]. The patient's past medical treatment, vaccination and family history were not provided. At the time of the event, the patient had ongoing Meat allergy. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) for prophylactic vaccination. On 13-Jul-2021, the patient received a first 0.5 mL dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number: U6920AB and expiry date : 15-Apr-2022) via an intramuscular route in the right arm for prophylactic vaccination. On 13-JUL-2021 the patient developed a non-serious itching at the injection site (vaccination site pruritus), vaccination site inflammation, redness at the injection site (vaccination site erythema) and mild swelling at the injection site (vaccination site swelling) same day following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. It was reported that, "Nurse practitioner reporting a dose of MENACTRA was administered today and the patient experienced a local reaction including redness, itching, and mild swelling at the injection site. Caller reporting she kept patient for observation for 15 minutes, and symptoms were improving. Caller reporting no medications administered. Caller reporting patient does have allergy to pork. Caller with question on whether MENACTRA contains traces of pork. Caller with question on whether it's okay for patient to receive MENACTRA in the future." Laboratory details were not reported. Unknown corrective treatment was received for events as patient kept for observation for 15 minutes (redness at the injection site, itching at the injection site, mild swelling at the injection site, Vaccination site inflammation). The patient was recovering from all the events (redness at the injection site, itching at the injection site, mild swelling at the injection site, Vaccination site inflammation) at the time of reported.
The child received routine vaccinations. Approx. 15 mins later, he fell to the floor suddenly and appeared to be convulsing. He recovered almost immediately but was pale. Transported by ambulance to the ER. Later the doctor reported no ill effects and was released to home. The next day mom reported that the child is doing fine.
allergic rxn p/vax large reddened area to hip w/hive formation;
This is a spontaneous report from a contactable consumer. A patient of unspecified age ethnicity and gender received PREVNAR 13 at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced some swelling and itching at the injection site on an unspecified date. The outcome of the events was unknown.
painful menstruation; difficulty of breathing; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSMENORRHOEA (painful menstruation), DYSPNOEA (difficulty of breathing) and CHILLS (Chills) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced DYSPNOEA (difficulty of breathing) and CHILLS (Chills). On 08-May-2021, the patient experienced DYSMENORRHOEA (painful menstruation). At the time of the report, DYSMENORRHOEA (painful menstruation), DYSPNOEA (difficulty of breathing) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with response to the events were not applicable.
Approx 2 hrs after being vaccinated on 6/5, I felt somewhat unwell. I checked my VS. My temp, SPO2, HR seemed to be WNL. My BP was somewhat higher than usual 141/96mmHg as I have no history of HTN and was not on any medication except for antihistamine for my allergies. I continued to monitor it throughout the rest of the day and it was gradually going up with the highest reading of 156/105mmHg that night with dizziness whether sitting or lying down.  The dizziness/headache and high diastolic continued on for almost 3.5 weeks everyday with warm sensation on  chest area around the heart on day 7 and day 8 from being vaccinated which I started taking garlic extract 1000mg on day 7 with the hopes of bring my bp down as I have no medication with me. I could not go back to working out as I was working out 3x/wk from 30 to 60mins prior to being vaccinated with my last workout day on 6/4. I was giving myself a week to let my body recuperate when my BP was not improving I scheduled an appointment with my primary.  At week 5 close to 6 week after being vaccinated, I only experience intermittent dizziness when my diastolic is higher than 10,  able to tolerate more activities without unreasonable BP elevation with some random chest pain which is not activity or time specific as it happens briefly whether sitting, lying or walking.
About 8 &1/2 hrs. after the baby had been given the Vaccine, the baby seemed 'floppy' and unresponsive per mom. No suggestion of any seizures. Baby was taken to the
slight burning sensation/irritation in the eyes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult male patient received bnt162b2 (BNT162B2), administration date 04Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EYE IRRITATION (non-serious) with onset 04Mar2021, outcome "unknown", described as "slight burning sensation/irritation in the eyes". Therapeutic measures were not taken as a result of eye irritation.  Additional information: It was reported covid prior vaccination and covid tested post vaccination was none and allergies were reported as unknown. Other vaccine in four weeks and other medications in two weeks were reported as Unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Felt weak; Muscle ache; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt weak), MYALGIA (Muscle ache), PYREXIA (Fever) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022c21a) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included MONOCLONAL ANTIBODIES for COVID-19.    On 17-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Felt weak), MYALGIA (Muscle ache), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, ASTHENIA (Felt weak), MYALGIA (Muscle ache), PYREXIA (Fever) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
1day p/vax pt exp papules that were very itchy. MD rpt pt went to ER for loose bowel movements & vomiting, IV for 4 hrs
pt recv vax & devel an inj site rxn consisting of a possible sterile abscess;no further info was available @ the date of this report;
At around 10:30pm on the day of the vaccine until I feel asleep after 2:00am, my heart hurt, my whole body ached, I was so cold my skin was red. My head hurt. I felt like I would pass out. Today, 4/1, I feel better but go from hot to cold and still feel aches with my head hurting earlier.
Blisters on Hand and fingers; Sore injection site; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blisters on Hand and fingers) and INJECTION SITE PAIN (Sore injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced BLISTER (Blisters on Hand and fingers) and INJECTION SITE PAIN (Sore injection site). At the time of the report, BLISTER (Blisters on Hand and fingers) and INJECTION SITE PAIN (Sore injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.  Treatment medications were not reported.   This case was linked to MOD-2021-122486, MOD-2021-122486 (Patient Link).
injection site was itchy, red, warm, and firm; injection site was itchy, red, warm, and firm; injection site was itchy, red, warm, and firm; injection site was itchy, red, warm, and firm; pain under her left arm near her left breast; very sore arm; This is a spontaneous report from a contactable nurse (patient herself). A 33-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Solution for injection; lot number: EJ1685, expiration date: unknown), intramuscularly on the left arm on 21Dec2020 at 12:00 PM at a single dose for COVID-19 immunization administered at the hospital. The patient had no medical history. The patient had no known allergies; there were no allergies to medications, food, or other products. There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On the first (1st) day after vaccine (22Dec2020), the patient experienced very sore arm, but no other effects until the 8th day after vaccine. On 28Dec2020 at 08:00, the patient started with pain under her left arm near her left breast. On 29Dec2020, the injection site was itchy, red, warm, and firm. The reporter assessed the events as non-serious. The patient did not receive any treatment for all the events. The patient was not recovered from the events "very sore arm, pain under her left arm near her left breast, and injection site was itchy, red, warm, and firm."
Presented w/ cough, SOB, fever, diarrhea. Recent dx of covid +. Tx w/ O2, Abx, Decadron, Remdesivir
I also contracted Lichen Planus as determined by a dermatologist that was directly related to the vaccine; I checked my blood pressure and it was extremely high at 170/122; chest tightness; Within 24 hours after the 2nd vaccine I had a massive headache that persisted for more then 3 days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old male patient received BNT162b2 (BNT162B2), on 07Sep2021 as dose 2, single (Lot number: EW0167) at the age of 54 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Mild hypertension" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. Concomitant medication(s) included: LISINOPRIL + HIDROCLOROTIAZIDA. Vaccination history included: coviD-19 mrna, lnp-s, pf (pfizer-biontech) (Dose Number: 1, Batch/Lot No: EW0186, Prev dose brand=COVID-19 mRNA, LNP-S, PF (Pfizer-BioNTech) Purple cap, Anatomical location: Left arm), administration date: 17Aug2021, when the patient was 54-year-old, for COVID-19 immunization. The following information was reported: HYPERTENSION (medically significant) with onset 09Sep2021, outcome "recovered with sequelae", described as "I checked my blood pressure and it was extremely high at 170/122"; CHEST DISCOMFORT (medically significant) with onset 09Sep2021, outcome "recovered with sequelae", described as "chest tightness"; HEADACHE (medically significant) with onset Sep2021, outcome "recovered with sequelae", described as "Within 24 hours after the 2nd vaccine I had a massive headache that persisted for more then 3 days"; LICHEN PLANUS (non-serious), outcome "unknown", described as "I also contracted Lichen Planus as determined by a dermatologist that was directly related to the vaccine". The events "within 24 hours after the 2nd vaccine i had a massive headache that persisted for more then 3 days", "i checked my blood pressure and it was extremely high at 170/122" and "chest tightness" required physician office visit. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: 170/122. Therapeutic measures were taken as a result of hypertension.  Clinical course: Reporter stated that, Patient had no Known allergies. Patient did not take any other vaccine in four weeks. Patient called the doctor's office and made an appointment they double checked the pressure and found it to be the same. They had to quadruple his blood pressure meds to get it back down. Patient still cannot go back to the lower dose as he had prior to the vaccine. Shortly after that episode patient contracted Lichen Planus as determined by a dermatologist that was directly related to the vaccine as well. Patient did not test with COVID post vaccination.
both of these people are fully vaccinated and boosted with Pfizer; both of these people are fully vaccinated and boosted with Pfizer; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 60-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "both of these people are fully vaccinated and boosted with Pfizer". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: Negative, notes: using rapid test; Positive, notes: using rapid test. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course : Male and Female Consumers (married couple) mentioned they had covid and were prescribed Paxlovid. They stated their symptoms resolved and texted negative (using rapid test), however within less than a week, their covid rebounded - their mild covid symptoms returned (fever, fluish) and they tested positive again (using rapid test). The case meet the seriousness criterion for Drug Ineffective, seriousness criteria updated The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
had some fever the next day 2NOV;not sure how much;rash broke out around mouth on rt side of face;rash resembles hives & bump on rt lower eyelid
Received GARDASIL shot on 8-12-13 at around 2 PM. Felt nauseous and vomited total of 6 times from 9 PM to 9 AM the following day. No diarrhea. Felt weak. Blood glucose 145.
2 1/2 X 2 1/2 inch raised area left deltoid.
Immediately after giving the shot and applying the band aid the patient fell forward and had a syncopal episode.  The patient came to about 5 seconds later and although he had to be reoriented briefly, was A&0x4.  He had a busted lip and a bruised and red area on his forehead. PERRLA.  BP 116/70.  Extremity Strength, strong and equal bilaterally.  The patient sat in the clinic for about an hour before he left and was monitored closely during this time.  The patient did have a second episode of syncope about 10 minutes after the first.  An ambulance was offered to the patient and his family member who was present and it was declined.  The patient was educated on signs/symptoms of a concussion and strongly advised to be evaluated by a doctor.  The patient does report experiencing a syncopal episode previously with a venipuncture.
Per patient's son, the patient developed a rash at the site of vaccination 4 days after the vaccine. She also began developing swollen, cracked lips and swollen hands and feet with a blistering rash. The symptoms were reported to our pharmacy by the patients son 28 days after her vaccine, on 3/15/21. The patient was due for her second dose on that day, and he wondered if she should still get it. We instructed him to call her Dr. After seeing her Dr for an appointment today, the patient was told not to get the second dose of the Moderna vaccine.
Post-menopausal x10 years and got a period- Cramps, bleeding exactly like when i had a monthly period.    I began to have the COVID symptoms all over again:  loss of taste and smell;  hair, eyebrows and eyelashes began to fall out; severe anxiety and brain fog
pt recvd vax & devel redness, tenderness & warmth @ the inject site;
Case number PHHY2012US021185 is an initial spontaneous report received from a physician on 06 Mar 2012. This report refers to a female neonate. The baby's mother (see case PHHY2010US71298) was vaccinated with FLUVIRIN (batch number: 111784P1) subcutaneously on 18 Oct 2010 when she was 7 months pregnant. On 18 Oct 2010, the baby's mother experienced red circle  of size 3 inches in diameter and pain at the injection site and at the fatty area of the arm. The baby's mother also had possible pre-eclampsia in the eighth month. On an unspecified date, the baby was born through normal delivery with low birth weight of 5 lbs 3 ozs and the mother was reported to have unspecified placental complications. The APGAR score for the child was unknown for the first, fifth and tenth minutes. The event's outcome and causality were not reported.
Pain to (L) deltoid started 23 hrs after vaccine and got progressively worse until 2 1/2 days  later. 5 cm raised tender rash around vaccine area started 36 hrs after vaccine. MOTRIN with relief prn. Rash is tender and warm.
Patient removed the bandaid from the injection site the same evening as her injection. She got into the shower and felt stinging on the injection site. She looked and noticed a nickel size area where her top layer of skin had slid off. Patient came back to the clinic the following day 10/15/2021 where she showed me her injection site.  I advised her to contact her primary care doctor and to report it to vaers. It was unclear if it was caused by vaccine, bandaid or someother reaction to creams/lotions/sprays.
On the morning after the Pfizer "booster" shot (Wednesday March 9, 2022), I woke up with extreme nausea and "shooting pains" in my head. When I sat up, I was very dizzy. As the day progressed, in addition to the nausea and headaches, I experienced the following: 1. Head: Lightheaded; Difficulty focusing/concentrating; Unusual lapses in memory  2. Heart: Intermittent pain/pressure (6/10) in chest 3: Lungs: Shortness of breath (Felt like "I could not catch my wind") 4. Generalized Body aches and Chills These symptoms were worse the first 2 days but continued for a week. PLEASE NOTE: The biggest concern is that I still have some residual memory issues and trouble focusing/concentrating
COVID-19 SCREEN: Have you had close contact with a laboratory-confirmed COVID-19 patient within 14 days no  Traveling in the last 14 days no  Fever? no Body aches? no Cough? no Shortness of Breath/difficulty breathing? no sorethroat?  no  Loss of taste/smell? no headache? no Nausea  no  Vomiting  no  Diarrhea no _______________________________ 41 year old female presents with swelling and soreness to right shoulder, arm, axilla, and breast since Friday evening (3 days ago). She received 2nd dose of Pfizer covid19 vaccine to the right arm on day previous on Thursday at 3:40pm. Friday evening also started with the whole right arm feeling heavy and numbness to the right 2nd finger, fever 101F, fatigue, chills, and brain fogginess.  Fever stopped the next day. 3/26/21 was first covid19 vaccine dose also to right arm, did not get any similar symptoms.  Taking 200mg ibuprofen every 6 hours, Tylenol 325mg every 4 hours for soreness.  Denies SOB, or pain or redness or rash at the injection site or redness at injection site.  Denies fever or chills at this time.  Deneis nausea, vomitng or diarrhea.
11/7/2022 Late afternoon I felt fatigue and facial pain behind eyes and over sinuses.  11/8 Nasal drainage, sneezing and a cough and chills developed.  11/9 Tested positive on an At Home COVID-19 test.  11/10 reached out to doctor through a televisit.   Doctor prescribed Paxlovid, which I did not take.  Also prescribed Baby aspirin, Vitamin D and C, Zinc.   Treated symptomatically with OTC cough medication.  Chills and cough tapered off over the course of 5 days.  Nasal drainage tapered off over 2 weeks.  A brief period with loss of smell, just 2 days towards the middle of the second week.  Fatigue lingered for about a month.
Administration of liquid portion of Menveo without reconstitution; Administration of liquid portion of Menveo without reconstitution; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.       Additional Information: GSK Receipt Date: 10-JUN-2022 Reporter's comment: The reporter reported that a patient received liquid portion of Menveo without reconstitution. Additional Supportive Information: The reporter reported that a patient received liquid portion of Menveo without reconstitution, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This case has been linked with the case US2022AMR091766 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR091766:Same reporter
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: RECOVERED ABOUT 5 MINUTES AFTER FAINTING. 911 WAS CALLED. PT RECOVERED IN 5 MINS